FIS
ACHL

FCPM III Services’s Achilles Therapeutics ACHL Stock Holding History

FCPM III Services’s Portfolio ACHL Stock Details ACHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,390,050
Closed -$2.75M – 8
2024
Q4 		$2.75M Hold
2,390,050
– – 0.46% 7
2024
Q3 		$2.44M Hold
2,390,050
– – 0.42% 7
2024
Q2 		$1.95M Hold
2,390,050
– – 0.29% 7
2024
Q1 		$2.99M Hold
2,390,050
– – 0.42% 6
2023
Q4 		$2.13M Buy
+2,390,050
New +$2.05M 0.63% 6

Other funds holding ACHL

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BAM
Brave Asset Management Summit, New Jersey $467M AUM 33.05% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

FCPM III Services's ACHL Position: Q1 2025 in Review

FCPM III Services sold out of Achilles Therapeutics (ACHL) in Q1 2025, closing a stake of 2,390,050 shares — an estimated $2.75M sold.

FCPM III Services first reported a position in ACHL in Q4 2023 and held it in 5 quarters. The position peaked at $2.99M in Q1 2024. 6 funds tracked by Wall St. Rank hold ACHL as of Q1 2025.

  • FCPM III Services reported no remaining Achilles Therapeutics position as of Q1 2025 after selling out during the quarter.
  • FCPM III Services sold 2,390,050 Achilles Therapeutics shares in Q1 2025, an estimated $2.75M.
  • FCPM III Services first reported a position in Achilles Therapeutics in Q4 2023 and held it in 5 quarters.
  • FCPM III Services's Achilles Therapeutics position peaked at $2.99M in Q1 2024.
  • 6 funds tracked by Wall St. Rank held Achilles Therapeutics as of Q1 2025.

Based on FCPM III Services's 13F filing for Q1 2025, filed 15 May 2025.